The study integrated peripheral CD4+ T cells from healthy individuals, autoimmunity patients (MS, SLE and myasthenia gravis) and other conditions [38] and created a machine learning model to predict T cell identity, representing a promising step towards integrating results across studies. This evidence concerns the gene CD4 and myeloid sarcoma.